MARTINO, Sabata
 Distribuzione geografica
Continente #
NA - Nord America 6.460
EU - Europa 5.447
AS - Asia 4.364
SA - Sud America 791
AF - Africa 78
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 4
Totale 17.153
Nazione #
US - Stati Uniti d'America 6.173
SG - Singapore 2.005
UA - Ucraina 922
IE - Irlanda 893
IT - Italia 801
HK - Hong Kong 765
BR - Brasile 664
CN - Cina 608
RU - Federazione Russa 574
SE - Svezia 522
DE - Germania 518
VN - Vietnam 472
GB - Regno Unito 305
FI - Finlandia 299
FR - Francia 283
CA - Canada 218
KR - Corea 217
PL - Polonia 59
TR - Turchia 54
MX - Messico 53
NL - Olanda 52
AT - Austria 48
CH - Svizzera 45
IN - India 45
AR - Argentina 44
ZA - Sudafrica 37
CZ - Repubblica Ceca 33
JP - Giappone 32
BD - Bangladesh 30
EC - Ecuador 24
UZ - Uzbekistan 24
BE - Belgio 23
ID - Indonesia 23
ES - Italia 16
CO - Colombia 13
LB - Libano 13
PK - Pakistan 12
UY - Uruguay 12
AE - Emirati Arabi Uniti 11
IQ - Iraq 11
LT - Lituania 10
MA - Marocco 10
VE - Venezuela 9
PY - Paraguay 8
GR - Grecia 7
PE - Perù 7
BY - Bielorussia 6
CI - Costa d'Avorio 6
CL - Cile 6
DK - Danimarca 6
KE - Kenya 6
EU - Europa 5
JO - Giordania 5
OM - Oman 5
SA - Arabia Saudita 5
JM - Giamaica 4
KG - Kirghizistan 4
PT - Portogallo 4
TN - Tunisia 4
AU - Australia 3
AZ - Azerbaigian 3
BG - Bulgaria 3
IL - Israele 3
NO - Norvegia 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BO - Bolivia 2
CR - Costa Rica 2
CY - Cipro 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GY - Guiana 2
HN - Honduras 2
IR - Iran 2
LU - Lussemburgo 2
LY - Libia 2
MD - Moldavia 2
MK - Macedonia 2
ML - Mali 2
MY - Malesia 2
NP - Nepal 2
TT - Trinidad e Tobago 2
AO - Angola 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GN - Guinea 1
HU - Ungheria 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MR - Mauritania 1
MW - Malawi 1
NI - Nicaragua 1
Totale 17.141
Città #
Singapore 1.199
Chandler 1.006
Dublin 893
Hong Kong 757
Jacksonville 508
San Mateo 474
Perugia 340
Ashburn 322
Boardman 316
Santa Clara 263
Dong Ket 237
Munich 227
Medford 220
Princeton 219
Seoul 217
Moscow 182
Wilmington 166
Beijing 159
Montréal 150
Ann Arbor 139
Altamura 136
Los Angeles 109
Lawrence 108
Andover 106
Ho Chi Minh City 99
Piscataway 90
Mcallen 86
Des Moines 82
Helsinki 81
New York 78
Saint Petersburg 67
São Paulo 67
Norwalk 50
Hanoi 47
Shanghai 46
The Dalles 45
Warsaw 37
Izmir 34
Woodbridge 33
Rome 31
Brooklyn 29
Turku 28
Montreal 27
Nuremberg 27
Redmond 27
Chicago 26
Johannesburg 26
London 26
Tokyo 25
Philadelphia 24
Vienna 24
Brno 23
Dallas 23
Amsterdam 22
Houston 22
San Paolo di Civitate 22
Atlanta 21
Stockholm 21
Brussels 20
Denver 20
Auburn Hills 19
Chennai 19
Redwood City 19
Boston 18
Poplar 18
San Francisco 18
Toronto 18
Falls Church 16
Mexico City 16
Falkenstein 14
Milan 14
Rio de Janeiro 14
San Diego 14
Città Di Castello 13
Columbus 13
Orem 13
Phoenix 13
Belo Horizonte 12
Council Bluffs 12
Hefei 12
Den Haag 11
Dhaka 11
Edinburgh 11
Florence 10
Guangzhou 10
Porto Alegre 10
Seattle 10
Ankara 9
Cambridge 9
Da Nang 9
Frankfurt am Main 9
Haiphong 9
Manchester 9
Montevideo 9
Mumbai 9
Tashkent 9
Lausanne 8
Paris 8
Querétaro 8
Quito 8
Totale 10.400
Nome #
Nanostructured Biopolymer-based Materials for Regenerative Medicine Applications 491
Intracerebral gene therapy in children with metachromatic leukodystrophy: Results of a phase I/II trial 161
Keratins extracted from Merino wool and Brown Alpaca fibres: thermal, mechanical and biological properties of PLLA based biocomposites 134
Carbon nanotubes and silver nanoparticles for multifunctional conductive polymer composites 129
Caspase 3 mediated PARP cleavage in lymphocytes from newborn babies of diabetic mothers 126
Tuning Stem Cells Fate by PLLA-based materials: A Matter of Mechanotransduction. 122
a-C:H NANOPATTERNED FILM DESIGNS DRIVE HUMAN BONE MARROW MESENCHYMAL STEM CELL CYTOSKELETON ARCHITECTURE 119
Absence of metabolic cross-correction in tay-sachs cells: implication in gene therapy 115
Adipose stem cell translational applications: From bench-to-bedside 114
In vivo HSV-1 T0Ahex gene transfer strategy for Tay-Sachs disease provides a wide distribution of B-Hexosaminidase A and restores the GM2 ganglioside metabolims in the brain animal model 113
b-Hexosaminidase and altered cell-mediated immuno-responce 113
Implication of Cathepsins S and D in TPO+IL-16-induced commitment of hematopoietic stem cell differentiation into tolerogenic dendritic cells 113
A comparison of lysosomal enzymes expression levels in peripheral blood of mild- and severe-Alzheimer’s disease and MCI patients: Implications for regenerative medicine approaches 111
Cellule staminali e GM2 gangliosidosi 108
Adult neural stem cells as a tool for gehe therapy of Tay-Sachs disease 106
Influence of cell differentiation and protein kinase C activation on sub-cellular distribution of beta-N-acetylhexosaminidases of HL 60 cells. 106
Human bone marrow mesenchymal stem cell guidance by a-C:H surface designes 104
Lysosomal enzymes in alzheimer disease and type 2 diabetes mellitus patients 104
Approcci di terapia genica per le malattie da accumulo metabolico lisosomiale con coinvolgimento neurologico 103
Absence of metabolic cross-correction in Tay-Sachs cells: implication in gene therapy 102
Lysosomal beta-Galactosidase and beta-Hexosaminidase Activities Correlate with Clinical Stages of Dementia Associated with Alzheimer's Disease and Type 2 Diabetes Mellitus 102
A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease 102
The processing of cysteinyl proteases during human hematopoietic stem cell commitment to CD1a-Dendritic cells 99
Novel bicistronic lentiviral vectors correct β-Hexosaminidase deficiency in neural and hematopoietic stem cells and progeny: implications for in vivo and ex vivo gene therapy of GM2 gangliosidosis 98
Expression of human a-subunit gene in the central nervous system of the Tay-Sachs animal model 97
B-Hexosaminidase and antigen presenting cells function: implication for neurodegenerative process in GM2 gangliosidosis 97
Advanced Tools of Regenerative Medicine for Neurodegenerative Diseases 97
Hydrogenated Amorphous Carbon Nanopatterned Film Designs Drive Human Bone Marrow Mesenchymal Stem Cell Cytoskeleton Architecture 97
Restoration of hexosaminidase A activity and GM2 ganglioside metabolism in cells from patients with Tay-Sachs Disease 96
B-Hexosaminidase and antigen presenting cells function: implication for neurodegenerative process in GM2 gangliosidosis 96
Protein Encapsulation in Biodegradable Polymeric Nanoparticles: Morphology, Fluorescence Behaviour and Stem Cell Uptake 96
Functionalized silica star-shaped nanoparticles and human mesenchymal stem cells: An in vitro model 96
Therapy for Lysosomal Storage Disorders: a Matter for Stem Cells 95
Analysis of galactocerebrosidase activity in the mouse brain by a-new hysological staining method 95
B-hexosaminidase isoenzymes and antigen presenting cell function: implication for neurodegenerative process in GM2-gangliosidosis 95
Above the Epitranscriptome: RNA Modifications and Stem Cell Identity 94
Optimized bicistronic lentiviral vectors to correct beta-hexosaminidase deficiency in neural and hematopoietic stem/progenitor cells and progeny 94
Novel nanocomposite PLA films with lignin/zinc oxide hybrids: Design, characterization, interaction with mesenchymal stem cells 94
Alpha and Beta subunits of b-N-acethyl-hexosaminidase are differently regulated during the mammalian brain development: implication for Tay-Sachs disease therapy 93
a-C:H nanopatterned grooves influence human bone marrow stromal stem cells orientation 92
Acid glycohydrolases activities in linphomonocytes plasma-membrane of patients with multiple sclerosis 92
Development of a New Tool for 3D Modeling for Regenarative Medicine 92
Integrated Computational Analysis Highlights unique miRNA Signatures in the Subventricular Zone and Striatum of GM2 Gangliosidosis Animal Models 92
Sistemi di "Drug delivery di B-esosaminidasi nella mallattia di Tay-Sachs 91
Effects of vitamin C on fibroblasts from sporadic Alzheimer's disease patients 91
Insight into mechanobiology: How stem cells feel mechanical forces and orchestrate biological functions 91
Specific determination of beta-galactocerebrosidase activity via competitive inhibition of beta-galactosidase 90
Effect of SWCNT introduction in random copolymers on material properties and fibroblast long term culture stability 90
"Terapia delle malattie neurodegenerative con cellule staminali: overview sullo stato attuale" 89
Proteomics and Epigenetic Mechanisms in Stem Cells 89
Efficient lentiviral vector-mediated delivery of hARSA in the brain of juvenile non-human primates 89
A New Analytical Bench Assay for the Determination of Arylsulfatase A Activity Toward Galactosyl-3-Sulfate Ceramide: Implication for Metachromatic Leukodystrophy Diagnosis 89
The processing of cysteinyl proteases during human hematopoietic stem cell commitment to CD1a-Dendritic cells 88
Widespread enzymatic correction of CNS tissues by a single intracerebral injection of therapeutic lentiviral vector in leukodystrophy mouse models. 88
Design of a nanocomposite substrate inducing adult stem cell assembly and progression toward an Epiblast-like or Primitive Endoderm-like phenotype via mechanotransduction 88
The Other Side of Alzheimer's Disease: Influence of Metabolic Disorder Features for Novel Diagnostic Biomarkers 88
Beta-Hexosaminidase expression is recapitulated in Neural Stem Cells induced to differentiate and in embryonic to adult brain development in both WT and knock-out mice 87
The influence of modified silica nanomaterials on adult stem cell culture 87
Generation of Human Induced Pluripotent Stem Cell-Derived Bona Fide Neural Stem Cells for Ex Vivo Gene Therapy of Metachromatic Leukodystrophy 87
MICROPATTERNED HYDROGENATED AMORPHOUS CARBON GUIDES MESENCHYMAL STEM CELLS TOWARDS NEURONAL DIFFERENTIATION 87
Localizzazione e caratterizzazione biochimica di forma di membrana nella b-n-acetilesosaminidase 86
Tuning multi pluri-potent stem cell fate by electrospun poly(L-lactic acid)-calcium-deficient hydroxyapatite nanocomposite mats. 86
Carbon nanotubes and silver nanoparticles for multifunctional conductive biopolymer composites 86
MicroRNAs and Molecular Mechanisms of Neurodegeneration 86
Brillouin spectroscopy for accurate assessment of morphological and mechanical characteristics in micro-structured samples 85
Molecular cloning and structural organization of the gene encoding the mouse lysosomal di-N-acetylchitobiase (ctbs) 84
Beta-Hexosaminidase and immuno-response: implications for the neurodegenerative process in GM2 gangliosidosis 84
Gene expression profiling identifies ARSD as a new marker of disease progression and the sphingolipid metabolism asa potential novel metabolism in Chronic Lymphocytic Leukemia 84
Stem cell-biomaterial interactions for regenerative medicine 84
In vivo gene therapy approach using herpes simplex vector for Tay-Sachs disease 83
Le cellule staminali stromali di midollo osseo umane sono orientate da nanotopografie di carbonio amorfo idrogenato 83
Lysosomal hydrolases in Alzheimers and type 2 diabetes mellitus patients 83
Biocompatible Poly(l-lactide)/MWCNT Nanocomposites: Morphological Characterization, Electrical Proprieties, and Stem Cell Interation. 83
Adult neural stem cells as a tool for gene therapy for Tay-Sachs disease. 82
Ex-vivo tissues engineering modeling for reconstructive surgery using human adult adipose stem cells and polymeric nanostructured matrix 82
Brain-directed gene transfer therapy for Tay-Sachs disease gives rice a wider distribution of the B-Hexosaminidase A 81
Neural precursor cell cultures from GM2 gangliosidosis animal models recapitulate the biochemical and molecular hallmarks of the brain pathology 81
Cathepsin S, Cathepsin D and Cystatin C Balance: an immunomodulator molecular mechanism 81
Critical issues for the proper diagnosis of Metachromatic Leukodystrophy 81
Characterization and localization of plasma membrane B-N-acetylhexosaminidases 81
Lentiviral haematopoietic stem cell gene therapy (HSC-GT) for metachromatic leukodystrophy (MLD): Preliminary results from a clinical trial with a cryopreserved formulation of OTL-200 81
Piezo1 controls cell volume and migration by modulating swelling-activated chloride current through Ca2+ influx 81
Beta-hexosaminidase and antigen presenting cell function: implication for neurodegenerative process in GM2 gangliosidosis. 80
Osteogenic Induction in human Bone Marrow mesenchymal Stem Cells by nonocomposite Scaffold 80
null 80
Restoration of the GM2 ganglioside metabolism in bone marrow-derived stromal cells from Tay-Sachs disease animal model 79
Microarray Gene Expression Signature Indicates ARSD As a New Marker Associated with Igvh Mutational Status, ZAP-70 and Disease Progression in CLL 79
MicroRNA mediated lysosomal enzymes down-regulation in cell of peripheral system from aAlzheimer's disease patients 79
Nanocomposites Based on PLLA and Multi Walled Carbon Nanotubes Support the Myogenic Differentiation of Murine Myoblast Cell Line 79
The role of physical cues in the development of stem cell-derived organoids 79
Regulation of neural stem cell compartment in a murine model of GM2-gangliosidosis: potential role of EGF and GM3 ganglioside 78
Mechanotransduction: Tuning Stem Cells Fate 78
Efficacy of combined gene/cell therapy in a murine model of Globoid cell Leukodystrophy 78
Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial 78
MicroRNA implications across neurodevelopment and neuropathology 78
De novo ssrna aptamers against the sars-cov-2 main protease: In silico design and molecular dynamics simulation 78
Neural Stem Cell Gene Therapy Ameliorates Pathology And Function In A Mouse Model Of Globoid Cell Leukodystrophy 77
Inclusion of multi walled carbon nanotubes on PLLA supports the myogenic differentiation of murine progenitor cells 77
ARSD as a new biomarker associated with IGVH, ZAP-70, and disease progression in CLL. 77
Modulating protein adsorption onto biomaterials by surface plasma treatment-VI Convegno Nazionale sulla Scienza e Tecnologia dei Materiali 76
Totale 9.642
Categoria #
all - tutte 78.040
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.040


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021976 0 0 0 0 0 94 153 5 222 61 171 270
2021/20221.723 29 354 73 98 54 21 21 517 14 67 192 283
2022/20233.105 246 444 62 228 274 384 18 148 1.155 7 112 27
2023/20241.521 205 143 81 30 18 18 274 72 207 55 131 287
2024/20253.301 49 322 148 111 429 165 221 204 611 216 591 234
2025/20263.652 564 430 398 959 1.043 258 0 0 0 0 0 0
Totale 17.752